-+ 0.00%
-+ 0.00%
-+ 0.00%

IGC Pharma Reaches 65% Enrollment in Phase 2 CALMA Trial for Alzheimer’s Agitation

路透·12/09/2025 14:00:41

登录查看新闻详情